Loading
Helix's test of 70 genes linked to inherited cancer risk, registered with the US genetic testing registry in 2026.
Registered in the NIH Genetic Testing Registry as GTR000619734.3 by Helix, Inc. (CLIA 05D2117342; created 20 March 2026, updated 25 March 2026): 70 genes, including the breast, ovarian, Lynch and polyposis genes, BAP1, DICER1, FLCN, MEN1, RET, VHL, the SDH genes, NF1, NF2 and SMARCB1. GTR records it as a test developed by the laboratory; it is not among the FDA-authorised hereditary cancer products.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Helix Hereditary Comprehensive Cancer Panel" OR ABSTRACT:"Helix Hereditary Comprehensive Cancer Panel") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Helix Hereditary Comprehensive Cancer Panel, not a curated reading list.
Shares Birt-Hogg-Dubé syndrome, FLCN, MSH2, MLH1 and the tags test, hereditary.
Shares Birt-Hogg-Dubé syndrome, MSH2, MLH1, PALB2 and the tags test, hereditary.
Shares MSH2, MLH1, Lynch syndrome, Hereditary cancer syndromes and the tags test, hereditary.
Shares MSH2, MLH1, PALB2, Lynch syndrome and the tags test, hereditary.
Shares Bloom syndrome, DICER1, PALB2, Hereditary cancer syndromes and the tags test, hereditary.
Shares MSH2, MLH1, PALB2, Lynch syndrome and the tags test, hereditary.
Shares MSH2, MLH1, PALB2, Lynch syndrome and the tags test, hereditary.
Shares Hereditary cancer syndromes, BRCA1 / BRCA2 (HRD), Germline (hereditary) testing and the tags test, hereditary.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/